New Delhi, Jan. 19 -- Brazil and Nigeria are emerging as key export destinations for Indian pharmaceutical companies amid global economic uncertainty, according to data from the commerce ministry.

Rising Exports to Emerging Markets

Nigeria was among the fastest-growing destinations during the first eight months of the current financial year, adding USD 179 million in exports and contributing over 14 per cent to total export growth. Brazil also recorded an increase of nearly USD 100 million in pharmaceutical exports during April-November FY26.

"These markets reflect rising healthcare access, expanding public procurement and growing reliance on Indian generics, reinforcing India's role as a preferred supplier to high-growth, demand-inten...